# Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

> **NCT04270279** · PHASE4 · UNKNOWN · sponsor: **Guang'anmen Hospital of China Academy of Chinese Medical Sciences** · enrollment: 120 (estimated)

## Conditions studied

- Coronary Heart Disease
- Stable Angina

## Interventions

- **DRUG:** Xueshuanxinmaining tablet
- **DRUG:** Xueshuanxinmaining placebo
- **DRUG:** Nitroglycerin tablets

## Key facts

- **NCT ID:** NCT04270279
- **Lead sponsor:** Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-12
- **Primary completion:** 2021-08
- **Final completion:** 2021-10
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04270279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04270279, "Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT04270279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*